Anar Dushpanova

 

Name

Anar Dushpanova 

Position

Acting assistant professor of department of the biomedical statistics and evidence-based medicine.

Academic Career

 post-graduate  degree PhD  dissertation

Ph.D course  in Innovative Strategies in Biomedical Research. Scuola Superiore Sant`Anna, Pisa, Italy

2013

graduate  degree General medicine. Western Kazakhstan  National Medical Academy named after  Marat Ospanov. Aktobe. 1999-2005

Research and development projects over the past five years

 

Research area: cardiology, physiology, genomics, molecular medicine.

Projects:

- STAT: Standard versus Tailored Anti-thrombotic Therapy.  Fondazione G. Monasterio. Massa,Italy.

-EUROASPIRE IV Study. European Survey of Cardiovascular Disease Prevention and Diabetes, Scientific Research Institute of Cardiology and Internal Disease Almaty.

-scientific and technical program «Elaboration of model of  innovative medical technology development in rural healthcare organizations of the Republic of Kazakhstan». Scientific Research Institute of Cardiology and Internal Disease Almaty.

-scientific and technical program «Elaboration and implementation of a modern system of major non-communicable diseases’ epidemiological monitoring to create innovative models of prevention and treatment programs in the Republic of Kazakhstan». Scientific Research Institute of Cardiology and Internal Disease Almaty.

Publications

 

Abstracts

1.  Rizza, M.De Carlo, C.Giannini, F. Buttita,  G.Triani, S.Sorbo, M.Ravani, A.S. Petronio, A.Balbarini, A.Dushpanova, S.Berti. “Distal embolization  of macroscopic debris during carotid artery stenting is predicted by circulating levels of LDL cholesterol and C-reactive protein”. MEET (Multidisciplinary European Endovascular Therapy). June 2009.

2.  M. Mariani, A. Dushpanova, M. Baroni, E. Cerone, A. Nardelli, J. Gianetti, S. Berti (Massa, Italy). “Role of an integrated score and comparison with other risk stratification scores and plasma BnP levels. Conference: 4th Official Congress of the Working Group on Acute Cardiac Care Location: Copenhagen, DENMARK Date:2010. EUROPEAN HEART JOURNAL SUPPLEMENTS  Volume: 12  Issue: F   Pages: F122-F122   Published: OCT 2010

3.  L.E. Pastormerlo, A. Dushpanova, F. Pali, D. Della Latta, A. Nardelli, D. Chiappino, M. Emdin, S. Maffei, Gabriele Monasterio Foundation, Department of Cardiovascular Medicine - Pisa - Italy, 2Gabriele Monasterio Foundation CNR/Region Toscana, Heart Hospital - Massa – Italy. Need for cardiac valvular surgery in 2011: preliminary results from a community screening of an Italian unselected population.  EUROPEAN HEART JOURNAL. Vol..32 Supplement 1 P. 841-841 Published: AUG 2011

4.  A. Flori, L. Menichetti, M. Liserani, F. Frijia, V. Lionetti, J. H. Ardenkjaer-Larsen , G. Bianchi , A. Dushpanova, G. Giovannetti , V. Positano , F. A. Recchia , L. Landini , M. F. Santarelli , M. Lombardi. Dissolution DNP with (1-13C) acetate for myocardial spectroscopic imaging in pigs.  8th Annual Meeting of the European Society for Molecular Imaging. Abstract is nominated for the EMIM 2013 Young Investigators Award.

5.  A. Dushpanova, S. Agostini, E. Ciofini, V. Casieri, M. Matteucci, A. Clerico, S. Berti, V. Lionetti - (1) Laboratory of Medical Science, Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy, Pisa, Italy (2) Gabriele Monasterio Foundation-CNR Region Toscana, Pisa, Italy Downregulation of von willebrand factor prevents angii-induced endothelin-1 expression independently of enos activation in porcine endothelial cells. ESC CONGRESS 2014.

6.  A. Dushpanova, S. Agostini, E. Ciofini, M. Cabiati, V. Casieri, M.Matteucci, S. Del Ry, A. Clerico, S. Berti, Lionetti Vincenzo. siRNA-mediated targeting of endothelial VWF prevents ET-1 upregulation in porcine aortic endothelial cells chronically exposed to angiotensin II. 56-56 VASCULAR PHARMACOLOGY (2015) Volume nr. : 75, Issue nr. : 1. SCImago Journal Rank (SJR): 1.313,  Impact Factor: 3.635, 5-Year Impact Factor: 2.974.

7.  B. Amirovа, Dushpanova A. « Multicenter study of the European Society of Cardiology “EUROASPIREIV” and the participation of ». Terapevticheskiy vestnik, special edition № 01, 2015 год.

Original full-text articles

1.  Parri MS, Gianetti J, Dushpanova A, Della Pina F, Saracini C, Marcucci R, Giusti B, Berti S. Pantoprazole significantly interferes with antiplatelet effect of       clopidogrel: Results of a pilot randomized trial. INTERNATIONAL JOURNAL OF CARDIOLOGYVol.167 Iss. 5 P. 2177-2181Published: SEP 1 2013 (Impact factor- 6.175 Scopus, Thomson Reuters) 

2.  Lionetti V, Romano SL, Bianchi G, Bernini F, Dushpanova A, Mascia G, Nesti M, Di Gregorio F, Barbetta A, Padeletti L. Impact of acute changes of left ventricular contractility on the transvalvular impedance: validation study by pressure-volume loop analysis in healthy pigs. PLOS ONE Vol.: 8 Iss. 11 Published: NOV 19 2013(Impact factor- 3.534, Scopus, Thomson Reuters).

3.  Anar Dushpanova, Silvia Agostini, EnricaCiofini, Manuela Cabiati, Valentina Casieri, Marco Matteucci, Silvia Del Ry, Aldo Clerico, Sergio Berti, and Vincenzo Lionetti Gene silencing of endothelial von Willebrand Factor attenuates angiotensin II-induced endothelin-1 expression in porcine aortic endothelial cells".  Scientific Reports» (Publisher Nature Publishing Group). IF 2015 – 5,228.

 4.  Anar Dushpanova et al. Aspirin resistance:  causes, principles of diagnostics, clinical outcomes. VestnikKazNMU № 2, 2016 г..

 5.  Zh.Romanova, Anar        Dushpanova. Modern alternative toxicity test methods, advantages and disadvantages, prospects of development in Kazakhstan. Vestnik KazNMU № 2, 2016

 6.  Kaibullaeva J.,Anar Dushpanova.The experience in the use of the drug DA-9601 (“Norvela”) in the treatment of NSAID-induced gastropathy. Pharmacy of Kazakhstan № 7, 2016 года.